IntelliPharmaCeutics International (TSXV:IPCI) Enterprise Value : C$5.12 Mil (As of May. 21, 2024)

IntelliPharmaCeutics International Enterprise Value Chart

IntelliPharmaCeutics International Annual Data
	Trend	Nov13	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22
Enterprise Value		Get a 7-Day Free Trial					1.81	6.85	6.29	6.24	6.33

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Enterprise Value	Get a 7-Day Free Trial															6.29	6.33	5.48	5.30	5.59

Competitive Comparison of IntelliPharmaCeutics International's Enterprise Value

For the Biotechnology subindustry, IntelliPharmaCeutics International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Enterprise Value distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Enterprise Value falls into.

IntelliPharmaCeutics International Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

IntelliPharmaCeutics International's Enterprise Value for the fiscal year that ended in Nov. 2022 is calculated as

IntelliPharmaCeutics International's Enterprise Value for the quarter that ended in Aug. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IntelliPharmaCeutics International  (TSXV:IPCI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

IntelliPharmaCeutics International's EV-to-EBIT for today is

IntelliPharmaCeutics International's current Enterprise Value is C$5.12 Mil.
IntelliPharmaCeutics International's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.89 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

IntelliPharmaCeutics International's EV-to-EBITDA for today is:

IntelliPharmaCeutics International's current Enterprise Value is C$5.12 Mil.
IntelliPharmaCeutics International's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.65 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

IntelliPharmaCeutics International's EV-to-Revenue for today is:

IntelliPharmaCeutics International's current Enterprise Value is C$5.12 Mil.
IntelliPharmaCeutics International's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IntelliPharmaCeutics International Enterprise Value Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description